Abstract
Obesity and vitamin D deficiency have both been linked to augmented activity of the tissue renin–angiotensin system (RAS). We investigated whether obesity status influenced the relationship between 25-hydroxyvitamin D (25(OH)D) and vascular RAS activity. The levels of 25(OH)D were measured in hypertensive obese (n=39) and non-obese (n=58) Caucasian individuals. RAS activity was assessed by plasma renin activity, and evaluation of the vascular sensitivity to angiotensin II (AngII) using the mean arterial pressure (MAP) response to an infusion of AngII. Among obese subjects, 25(OH)D was an independent positive predictor of the MAP response to AngII (β=0.70, r=0.41, P<0.01); lower 25(OH)D concentrations were associated with a blunted MAP response to AngII. In contrast, 25(OH)D did not significantly predict the vascular sensitivity to AngII in non-obese subjects (β=0.10, r=0.07, P=0.62). A multivariable-adjusted interaction model confirmed that the positive relationship between 25(OH)D and the vascular sensitivity to AngII strengthened with obesity (P-interaction=0.03). These findings demonstrate a positive association between 25(OH)D and the vascular sensitivity to AngII in obese hypertensives, and further suggest that vascular RAS activity may progressively increase when 25(OH)D deficiency occurs in obesity. Future studies to evaluate the effect of vitamin D supplementation on vascular RAS activity in obesity are needed.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bierschenk L, Alexander J, Wasserfall C, Haller M, Schatz D, Atkinson M . Vitamin D levels in subjects with and without type 1 diabetes residing in a solar rich environment. Diabetes Care 2009; 32 (11): 1977–1979.
Catenacci VA, Hill JO, Wyatt HR . The obesity epidemic. Clin Chest Med 2009; 30 (3): 415–444, vii.
Holick MF . Vitamin D deficiency. N Engl J Med 2007; 357 (3): 266–281.
Pilz S, Tomaschitz A, Ritz E, Pieber TR . Vitamin D status and arterial hypertension: a systematic review. Nat Rev Cardiol 2009; 6 (10): 621–630.
Tuck ML, Sowers J, Dornfeld L, Kledzik G, Maxwell M . The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N Engl J Med 1981; 304 (16): 930–933.
Cooper R, McFarlane-Anderson N, Bennett FI, Wilks R, Puras A, Tewksbury D et al. ACE, angiotensinogen and obesity: a potential pathway leading to hypertension. J Hum Hypertens 1997; 11 (2): 107–111.
Umemura S, Nyui N, Tamura K, Hibi K, Yamaguchi S, Nakamaru M et al. Plasma angiotensinogen concentrations in obese patients. Am J Hypertens 1997; 10 (6): 629–633.
Engeli S, Bohnke J, Gorzelniak K, Janke J, Schling P, Bader M et al. Weight loss and the renin-angiotensin-aldosterone system. Hypertension 2005; 45 (3): 356–362.
Engeli S, Negrel R, Sharma AM . Physiology and pathophysiology of the adipose tissue renin-angiotensin system. Hypertension 2000; 35 (6): 1270–1277.
Engeli S, Schling P, Gorzelniak K, Boschmann M, Janke J, Ailhaud G et al. The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome? Int J Biochem Cell Biol 2003; 35 (6): 807–825.
Bentley-Lewis R, Adler GK, Perlstein T, Seely EW, Hopkins PN, Williams GH et al. Body mass index predicts aldosterone production in normotensive adults on a high-salt diet. J Clin Endocrinol Metab 2007; 92 (11): 4472–4475.
Sarzani R, Salvi F, Dessi-Fulgheri P, Rappelli A . Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans. J Hypertens 2008; 26 (5): 831–843.
Mazzolai L, Nussberger J, Aubert JF, Brunner DB, Gabbiani G, Brunner HR et al. Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system. Hypertension 1998; 31 (6): 1324–1330.
Dluhy RG, Williams GH . Aldosterone—villain or bystander? N Engl J Med 2004; 351 (1): 8–10.
Li YC . Vitamin D regulation of the renin-angiotensin system. J Cell Biochem 2003; 88 (2): 327–331.
Li YC . Inhibition of renin: an updated review of the development of renin inhibitors. Curr Opin Investig Drugs 2007; 8 (9): 750–757.
Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP . 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002; 110 (2): 229–238.
Zhang Z, Zhang Y, Ning G, Deb DK, Kong J, Li YC . Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase. Proc Natl Acad Sci USA 2008; 105 (41): 15896–15901.
Zhang Y, Deb DK, Kong J, Ning G, Wang Y, Li G et al. Long-term therapeutic effect of vitamin d analog doxercalciferol on diabetic nephropathy: strong synergism with at1 receptor antagonist. Am J Physiol Renal Physiol 2009; 297 (3): F791–F801.
Resnick LM, Muller FB, Laragh JH . Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. Ann Intern Med 1986; 105 (5): 649–654.
Tomaschitz A, Pilz S, Ritz E, Grammer T, Drechsler C, Boehm BO et al. Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system The Ludwigshafen Risk and Cardiovascular Health (LURIC) Study. Clin Chim Acta 2010; 411 (17–18): 1354–1360.
Forman JP, Williams JS, Fisher ND . Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension 2010; 55 (5): 1283–1288.
Hollenberg NK, Williams GH, Taub KJ, Ishikawa I, Brown C, Adams DF . Renal vascular response to interruption of the renin-angiotensin system in normal man. Kidney Int 1977; 12 (4): 285–293.
Shoback DM, Williams GH, Moore TJ, Dluhy RG, Podolsky S, Hollenberg NK . Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension. J Clin Invest 1983; 72 (6): 2115–2124.
Hopkins PN, Lifton RP, Hollenberg NK, Jeunemaitre X, Hallouin MC, Skuppin J et al. Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity. J Hypertens 1996; 14 (2): 199–207.
Faloia E, Gatti C, Camilloni MA, Mariniello B, Sardu C, Garrapa GG et al. Comparison of circulating and local adipose tissue renin-angiotensin system in normotensive and hypertensive obese subjects. J Endocrinol Invest 2002; 25 (4): 309–314.
Ahmed SB, Fisher ND, Stevanovic R, Hollenberg NK . Body mass index and angiotensin-dependent control of the renal circulation in healthy humans. Hypertension 2005; 46 (6): 1316–1320.
Chamarthi B, Williams JS, Williams GH . A mechanism for salt-sensitive hypertension: abnormal dietary sodium-mediated vascular response to angiotensin-II. J Hypertens 2010; 28 (5): 1020–1026.
Lely AT, Krikken JA, Bakker SJ, Boomsma F, Dullaart RP, Wolffenbuttel BH et al. Low dietary sodium and exogenous angiotensin II infusion decrease plasma adiponectin concentrations in healthy men. J Clin Endocrinol Metab 2007; 92 (5): 1821–1826.
Arunabh S, Pollack S, Yeh J, Aloia JF . Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab 2003; 88 (1): 157–161.
Snijder MB, van Dam RM, Visser M, Deeg DJ, Dekker JM, Bouter LM et al. Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab 2005; 90 (7): 4119–4123.
Young KA, Engelman CD, Langefeld CD, Hairston KG, Haffner SM, Bryer-Ash M et al. Association of plasma vitamin d levels with adiposity in Hispanic and African Americans. J Clin Endocrinol Metab 2009; 94 (9): 3306–3313.
Cheng S, Massaro JM, Fox CS, Larson MG, Keyes MJ, McCabe EL et al. Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study. Diabetes 2010; 59 (1): 242–248.
Raji A, Williams GH, Jeunemaitre X, Hopkins PN, Hunt SC, Hollenberg NK et al. Insulin resistance in hypertensives: effect of salt sensitivity, renin status and sodium intake. J Hypertens 2001; 19 (1): 99–105.
Williams JS, Williams GH, Jeunemaitre X, Hopkins PN, Conlin PR . Influence of dietary sodium on the renin-angiotensin-aldosterone system and prevalence of left ventricular hypertrophy by EKG criteria. J Hum Hypertens 2005; 19 (2): 133–138.
Centers for Disease Control and Prevention. The Third National Health and Nutrition Examination Survey III (NHANES 1988-94) Reference Manuals and Reports [CD-ROM]. National Center for Health Statistics 1996 Bethesda, MD.
Dickinson BD, Havas S . Reducing the population burden of cardiovascular disease by reducing sodium intake: a report of the Council on Science and Public Health. Arch Intern Med 2007; 167 (14): 1460–1468.
Brown NJ, Agirbasli MA, Williams GH, Litchfield WR, Vaughan DE . Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1. Hypertension 1998; 32 (6): 965–971.
Lind L, Wengle B, Wide L, Ljunghall S . Reduction of blood pressure during long-term treatment with active vitamin D (alphacalcidol) is dependent on plasma renin activity and calcium status. A double-blind, placebo-controlled study. Am J Hypertens 1989; 2 (1): 20–25.
Achinger SG, Ayus JC . The role of vitamin D in left ventricular hypertrophy and cardiac function. Kidney Int Suppl 2005; 95): S37–S42.
Vaidya A, Forman JP . Vitamin D and hypertension: current controversies and future directions. Hypertension 2010; 56 (5): 774–779.
Danser AH . Local renin-angiotensin systems. Mol Cell Biochem 1996; 157 (1–2): 211–216.
Price DA, Fisher ND, Lansang MC, Stevanovic R, Williams GH, Hollenberg NK . Renal perfusion in blacks: alterations caused by insuppressibility of intrarenal renin with salt. Hypertension 2002; 40 (2): 186–189.
Hollenberg NK, Williams GH . Abnormal renal function, sodium-volume homeostasis and renin systm behavior in normal-renin essential hypertension: the evolution of the non-modulation concept. In: Laragh and BM Brenner (eds). Hypertension: Pathophysiology, Diagnosis, and Management. Raven Press, Ltd: New York, 1995, 1837–1856.
Price DA, Fisher ND . The renin-angiotensin system in blacks: active, passive, or what? Curr Hypertens Rep 2003; 5 (3): 225–230.
Forman JP, Price DA, Stevanovic R, Fisher ND . Racial differences in renal vascular response to angiotensin blockade with captopril or candesartan. J Hypertens 2007; 25 (4): 877–882.
Resnick LM . Calciotropic hormones in human and experimental hypertension. Am J Hypertens 1990; 3 (8 Part 2): 171S–178S.
Resnick LM . Calciotropic hormones in salt-sensitive essential hypertension: 1,25-dihydroxyvitamin D and parathyroid hypertensive factor. J Hypertens Suppl 1994; 12 (1): S3–S9.
Acknowledgements
We would like to thank the staff of the clinical research centre at our collaborating institutions. Funding support: National Institutes of Health grants K23 HL04236-03 (JSW), K08 HL079929 (JPF), F32 HL104776-01 (AV) and UL1 RR025758 Harvard Clinical and Translational Science Center, from the National Center for Research Resources and M01-RR02635, Brigham & Women's Hospital, General Clinical Research Center and from the National Center for Research Resources. The content is sole responsibility of us and does not necessarily represent the official views of the National Library of Medicine, the National Institutes of Health or the National Center for Research Resources.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Vaidya, A., Forman, J. & Williams, J. Vitamin D and the vascular sensitivity to angiotensin II in obese Caucasians with hypertension. J Hum Hypertens 25, 672–678 (2011). https://doi.org/10.1038/jhh.2010.110
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jhh.2010.110
Keywords
This article is cited by
-
Angiotensin II and post-streptococcal glomerulonephritis
Clinical and Experimental Nephrology (2024)
-
Parathyroid diseases and metabolic syndrome
Journal of Endocrinological Investigation (2023)
-
Angiotensin II and dengue
Archives of Virology (2023)
-
Effects of high- vs low-dose native vitamin D on albuminuria and the renin–angiotensin–aldosterone system: a randomized pilot study
International Urology and Nephrology (2022)
-
Vitamin D deficiency and risk of cardiovascular diseases: a narrative review
Clinical Hypertension (2018)